Abstract

Background To observe different roles of direct bilirubin (Dbil) on portopulmonary hypertension (POPH) and idiopathic pulmonary arterial hypertension (IPAH). Methods Thirty incident patients with POPH and 180 with IPAH (matched by the WHO functional classification in a 1 : 6 ratio) between March 2010 and December 2020 were included. The receiver operating curve and Kaplan–Meier method were applied to estimate the ability to distinguish between the two and survival, respectively. Univariate and forward multiple stepwise regression analyses were performed to access the relationship between pulmonary vascular resistance (PVR) and clinical indices. Results Compared to IPAH, the POPH group had better hemodynamics including PVR (7.08 ± 3.95 vs. 14.89 ± 7.11, P < 0.001) and higher total bilirubin (Tbil) and Dbil. Tbil and Dbil had a negative correlation with PVR in the POPH group (r = −0.394, P=0.031; r = −0.364, P=0.048, respectively) but positive correlation in the IPAH group (r = 0.218, P=0.003; r = 0.178, P=0.018, respectively). Increased neutrophil counts (r = 0.394, P=0.031) and elevated NT-proBNP (r = 0.433, P < 0.001) would help predict the elevation of PVR in POPH and IPAH groups independent of Dbil, respectively. Dbil could distinguish POPH from IPAH (AUC = 0.799, P=0.009), and the ability was elevated when taking aspartate aminotransferase together (AUC = 0.835, P < 0.001). The overall survival was better in POPH than in IPAH (7 dead cases of POPH and 96 of IPAH, P=0.002). Survival was better in POPH than in IPAH in the group of Dbil ≥7 μmol/L (P=0.001) but showed no significant difference between POPH and IPAH in the group of Dbil <7 μmol/L (P=0.192). Conclusions The POPH group had a better hemodynamic profile than IPAH. Dbil was associated oppositely with the elevation of PVR in POPH and IPAH. Patients with POPH had better survival than those with IPAH in the total cohort and in the group of Dbil ≥7 μmol/L, but limited dead cases of POPH should be noted.

Highlights

  • Portopulmonary hypertension (POPH) is a life-threatening disease with damage to both pulmonary circulation and portal circulation with or without liver diseases, defined as Group 1 pulmonary hypertension (PH) and a severe complication of portal hypertension [1,2,3,4,5]

  • A total of 30 POPH (8 men) and 180 idiopathic pulmonary arterial hypertension (IPAH) (57 men) patients were included in this study. e mean time of follow-up was 70.23 ± 41.74 months

  • Patients with POPH were older than patients with IPAH (49.5 ± 13.1 vs. 39.1 ± 14.9 years old, P < 0.001)

Read more

Summary

Introduction

Portopulmonary hypertension (POPH) is a life-threatening disease with damage to both pulmonary circulation and portal circulation with or without liver diseases, defined as Group 1 pulmonary hypertension (PH) and a severe complication of portal hypertension [1,2,3,4,5]. Bilirubin, including total bilirubin and direct bilirubin, is one indicator of liver function abnormality and had an association with PAH. To observe different roles of direct bilirubin (Dbil) on portopulmonary hypertension (POPH) and idiopathic pulmonary arterial hypertension (IPAH). Compared to IPAH, the POPH group had better hemodynamics including PVR (7.08 ± 3.95 vs 14.89 ± 7.11, P < 0.001) and higher total bilirubin (Tbil) and Dbil. Survival was better in POPH than in IPAH in the group of Dbil ≥7 μmol/L (P 0.001) but showed no significant difference between POPH and IPAH in the group of Dbil

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.